Defense Advanced Research Projects AgencyTagged Content List

Threat Countermeasures

Actions that mitigate adversaries' capabilities

Showing 80 results for Countermeasures RSS
The Friend or Foe program aims to develop biosurveillance technology that can detect bacterial pathogens as, or even before, they threaten the military and homeland. The goal of the program is to quickly determine whether an unknown bacterium is harmless or virulent by directly identifying pathogenic behavior, avoiding conventional strategies that rely on known biomarkers.
The Gamma Ray Inspection Technology (GRIT) program seeks transformational approaches to achieving high-intensity, tunable, and narrow-bandwidth gamma ray production, but in a compact form factor suitable for transporting the source to where the capability is needed.
The Insect Allies program is pursuing scalable, readily deployable, and generalizable countermeasures against potential natural and engineered threats to the food supply with the goals of preserving the U.S. crop system. National security can be quickly jeopardized by naturally occurring threats to the crop system, including pathogens, drought, flooding, and frost, but especially by threats introduced by state or non-state actors. Insect Allies seeks to mitigate the impact of these incursions by applying targeted therapies to mature plants with effects that are expressed at relevant timescales—namely, within a single growing season.
DARPA’s Mobile Force Protection (MFP) program focuses on a challenge of increasing concern to the U.S. military: thwarting the proliferation of small, unmanned aircraft systems. These systems – which include fixed- or rotary-wing aircraft and have numerous advantages such as portability, low cost, commercial availability, and easy upgradeability – pose a fast-evolving array of dangers for U.S. ground and maritime convoys.
The Nucleic acids On-demand Worldwide (NOW) program aims to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to rapidly produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA).